European research priorities for intracerebral haemorrhage

Cerebrovascular Diseases

Volumn 32, Issue 5, 2011, Pages 409-419

  Steiner, Thorsten ^m   Petersson, Jesper ⁱ   Al Shahi Salman, Rustam ^a   Christensen, Hanne ^c   Cordonnier, Charlotte ^d   Csiba, Laszlo ^f   Harnof, Sagi ^g   Krieger, Derk ^c   Mendelow, David ^b   Molina, Carlos ^h   Montaner, Joan ^h   Overgaard, Karsten ^c   Roine, Risto O ^j   Schmutzhard, Erich ^l   Tatlisumak, Turgut ^k   Toni, Danilo ⁿ   Stapf, Christian ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c Capital Region of Copenhagen ^*  (Denmark)

^d UNIV LILLE   (France)

^e HÔPITAL LARIBOISIÈRE   (France)

^f UNIVERSITY OF DEBRECEN   (Hungary)

^g SHEBA MEDICAL CENTER   (Israel)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j TURKU UNIVERSITY HOSPITAL   (Finland)

^k HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^l UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^m UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

ⁿ SAPIENZA UNIVERSITY OF ROME   (Italy)

more..

Author keywords

Disability; Epidemiology; Imaging; Intracerebral haemorrhage; Mortality; Oedema; Outcome; Pathophysiology; Stroke

Indexed keywords

ACEXAMIC ACID; ANTICOAGULANT AGENT; HEMOSTATIC AGENT; INDAPAMIDE; PERINDOPRIL; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; WARFARIN;

BLEEDING; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL STUDY; DISABILITY; DRUG FATALITY; EUROPE; HEALTH PROGRAM; HEMOSTASIS; HUMAN; INCIDENCE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; STROKE;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CEREBRAL HEMORRHAGE; EUROPE; HUMANS; INCIDENCE; NEUROSURGERY; RESEARCH;

EID: 80053556623     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000330653     Document Type: Review

References (92)

1. Al-Shahi Salman R, Labovitz DL, Stapf C: Spontaneous intracerebral haemorrhage. BMJ 2009; 339:b2586.
2. Lovelock CE, Molyneux AJ, Rothwell PM: Change in incidence and aetiology of intra-cerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007; 6:487-493.
3. Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ: Incidence, case fatality, and functional outcome of intracere-bral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta analysis. Lancet Neurol 2010; 9: 167-176.
4. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V: Worldwide stroke incidence and early case fatality reported in 56 population-based studies: aA systematic review. Lancet Neurol 2009; 8: 355-369.
5. World Health Organisation: Global burden of disease. Geneva, WHO, 2010.
6. Di Carlo A: Human and economic burden of stroke. Age Ageing 2009; 38:4-5.
7. Weimar C, Weber C, Wagner M, Busse O, Haberl RL, Lauterbach KW, Diener HC: Management patterns and health care use after intracerebral hemorrhage: a cost-of-ill-ness study from a societal perspective in Germany. Cerebrovasc Dis 2003; 15:29-36. (Pubitemid 36131895)
8. Muller-Nordhorn J, Binting S, Roll S, Willich SN: An update on regional variation in cardiovascular mortality within Europe. Eur Hear t J 2008; 29: 1316-1326. (Pubitemid 351768126)
9. Lovelock CE, Rinkel GJ, Rothwell PM: Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 2010; 74:1494-1501.
10. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ: Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009; 8:635-642.
11. A l-Shahi Salman R, Sud low CL: Case fatality after subarachnoid haemorrhage: declining, but why? Lancet Neurol 2009; 8: 598-599.
12. Van der Schaaf I, Algra A, Wermer M, Moly-neux A, Clarke M, van Gijn J, Rinkel G: Endovascular coiling versus neurosurgical clipping for patients with aneurysmal sub-arachnoid haemorrhage. Cochrane Database Syst Rev 2005; 4:CD003085.
13. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, Mondo C, Dam-asceno A, Lopez-Jaramillo P, Hankey GJ, Dans AL, Yusoff K, Truelsen T, Diener HC, Sacco RL, Ryglewicz D, Czlonkowska A, Weimar C, Wang X, Yusuf S: Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the Interstroke Study): a case-control study. Lancet 2010; 376: 112-12 3.
14. Ariesen MJ, Claus SP, Rinkel GJ, Algra A: Risk factors for intracerebral hemorrhage in the general population: a systematic review. St roke 2003; 34: 2060-2065. (Pubitemid 36944806)
15. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T: Hematoma growth is a determinant of mortality and poor outcome after in-tracerebral hemorrhage. Neurology 2006; 66: 1175-1181. (Pubitemid 43739699)
16. Sansing LH, Kaznatcheeva EA, Perkins CJ, Komaroff E, Gutman FB, Newman GC: Edema after intracerebral hemorrhage: correlations with coagulation parameters and treatment. J Neurosurg 2003; 98:985-992. (Pubitemid 36460889)
17. Xi G: Intracerebral hemorrhage: pathophysi-ology and therapy. Neurocrit Care 2004; 1: 5-18.
18. Gong C, Boulis N, Qian J, Turner DE, Hoff JT, Keep RF: Intracerebral hemorrhage-induced neuronal death. Neurosurgery 2001; 48:875-882.
19. Lu A, Tang Y, Ran R, Ardizzone TL, Wagner KR, Sharp FR: Brain genomics of intracere-bral hemorrhage. J Cereb Blood Flow Metab 2006; 26: 230-252.
20. Strbian D, Durukan A, Tatlisumak T: Rodent models of hemorrhagic stroke. Curr Pharm Des 20 08; 1 4: 352-35 8. (Pubitemid 351522655)
21. Weir CJ, Murray GD, Adams FG, Muir KW, Grosset DG, Lees KR: Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet 1994; 344: 999-1002. (Pubitemid 24306558)
22. Badam P, Solao V, Pai M, Kalantri SP: Poor accuracy of the Siriraj and Guy's Hospital stroke scores in distinguishing haemor-rhagic from ischaemic stroke in a rural, tertiary care hospital. Natl Med J India 2003; 16: 8-12. (Pubitemid 36503230)
23. Soman A, Joshi SR, Tarvade S, Jayaram S: Greek stroke score, Siriraj score and Allen score in clinical diagnosis of intracerebral hemorrhage and infarct: validation and comparison study. Indian J Med Sci 2004; 58: 417-422. (Pubitemid 39586482)
24. Godoy DA, Pinero G, Di Napoli M: Predicting mortality in spontaneous intracerebral hemorrhage: can modification to original score improve the prediction? Stroke 2006; 37: 1038-10 4 4.
25. Kolapo KO, Ogun SA, Danesi MA, Osalusi BS, Odusote KA: Validation study of the Siri-raj stroke score in African Nigerians and evaluation of the discriminant values of its parameters: a preliminary prospective CT scan study. Stroke 2006; 37: 1997-2000. (Pubitemid 44309893)
26. Ozeren A, Bicakci S, Burgut R, Sarica Y, Bozdemir H: Accuracy of bedside diagnosis versus Allen and Siriraj stroke scores in Turkish patients. Eur J Neurol 2006; 13: 611-615. (Pubitemid 43873633)
27. Connor MD, Modi G, Warlow CP: Accuracy of the Siriraj and Guy's Hospital stroke scores in urban South Africans. Stroke 2007; 38: 62-68. (Pubitemid 46035607)
28. Valiente RA, de Miranda-Alves MA, Silva GS, Gomes DL, Brucki SM, Rocha MS, Massaro AR: Clinical features associated with early hospital arrival after acute intracere-bral hemorrhage: challenges for new trials. Cerebrovasc Dis 2008; 26: 404-408.
29. Lovelock CE, Anslow P, Molyneux AJ, Byrne JV, Kuker W, Pretorius PM, Coull A, Rothwell PM: Substantial observer variability in the differentiation between primary intrace-rebral hemorrhage and hemorrhagic transformation of infarction on CT brain imaging. Stroke 2009; 40: 3763-3767.
30. Kidwell CS, Wintermark M: Imaging of intracranial haemorrhage. Lancet Neurol 2008; 7:256-267. (Pubitemid 351215984)
31. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC: The ICH score: a simple, reliable grading scale for intracere-bral hemorrhage. Stroke 2001; 32:891-897.
32. Wada R, Aviv RI, Fox AJ, Sahlas DJ, Gladstone DJ, Tomlinson G, Symons SP: CT an-giography 'spot sign' predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 2007; 38: 1257-1262. (Pubitemid 351664234)
33. Ederies A, Demchuk A, Chia T, Gladstone DJ, Dowlatshahi D, Bendavit G, Wong K, Symons SP, Aviv RI: Postcontrast CT extravasation is associated with hematoma expansion in CTA spot negative patients. Stroke 2009; 40:1672-1676.
34. Hallevi H, Abraham AT, Barreto AD, Grotta JC, Savitz SI: The spot sign in intracerebral hemorrhage: the importance of looking for contrast extravasation. Cerebrovasc Dis 2010; 29:217-220.
35. Havsteen I, Christensen A, Nielsen JK, Christensen L, Krieger DW, Christensen H: E-learn computed tomographic angiogra-phy: a proposed educational tool for computed tomographic angiography in acute stroke. J Stroke Cerebrovasc Dis 2011, E-pub ahead of print.
36. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M: Guidelines for the management of spontaneous intracerebral hemorrhage in adults-2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007; 38: 2001-2023.
37. Steiner T, Kaste M, Forsting M, Mendelow D, Kwiecinski H, Szikora I, Juvela S, Marchel A, Chapot R, Cognard C, Unterberg A, Hacke W: Recommendations for the management of intracranialh aemorrhage. 1. Spontaneous intracerebral haemorrhage. The European Stroke Initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis 2006; 22:294-316.
38. Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, Greenberg SM, Huang JN, Macdonald RL, Messe SR, Mitchell PH, Selim M, Tamargo RJ: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41:2108-2129.
39. Cordonnier C, Klijn CJ, van Beijnum J, Al-Shahi Salman R: Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey. Stroke 2010; 41:685-690.
40. Fiebach JB, Schellinger PD, Gass A, Kucinski T, Siebler M, Villringer A, Olkers P, Hirsch JG, Heiland S, Wilde, Jansen O, Rother J, Hacke W, Sartor K: Stroke magnetic resonance imaging is accurate in hyperacute in-tracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 2004; 35: 502-506. (Pubitemid 38174437)
41. Goldstein JN, Fazen LE, Snider R, Schwab K, Greenberg SM, Smith EE, Lev MH, Rosand J: Contrast ext ravasation on CT angiog raphy predicts hematoma expansion in intracere-bral hemorrhage. Neurology 2007; 68:889-894. (Pubitemid 46568499)
42. Murai Y, Ikeda Y, Teramoto A, Tsuji Y: Magnetic resonance imaging-documented extravasation as an indicator of acute hypertensive intracerebral hemorrhage. J Neuro-surg 1998; 88:650-655. (Pubitemid 28145207)
43. Nguyen TN, Rordorf G, Schwamm LH, Smith EE: MRI contrast extravasation with enlarging hyperacute thrombolysis-related hemorrhage. Neurology 2006; 66:E30.
44. Mayer SA, Davis SM, Skolnick BE, Brun NC, Begtrup K, Broderick JP, Diringer MN, Steiner T: Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke 2009; 3: 833-840.
45. Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Oleinik A, Brouwers HB, Goldstein JN, Rosand J, Lev MH, Gonzalez RG, Romero JM: The spot sign score in primary intrace-rebral hemorrhage identifies patients at highest risk of in-hospital mortality and poor outcome among survivors. Stroke 2010; 41:54-60.
46. Perez ES, Delgado-Mederos R, Rubiera M, Delgado P, Ribo M, Maisterra O, Ortega G, Alvarez-Sabin J, Molina CA: Transcranial duplex sonography for monitoring hyper-acute intracerebral hemorrhage. Stroke 2009; 40:987-990.
47. Hwang BY, Appelboom G, Kellner CP, Carpenter AM, Kellner MA, Gigante PR, Sander Connolly E: Clinical grading scales in intra-cerebral hemorrhage. Neurocrit Care 2010; 13: 141-151.
48. Wallentin L, Yusuf S, Ezekowitz MD, Alings M, Flather M, Franzosi MG, Pais P, Dans A, Eikelboom J, Oldgren J, Pogue J, Reilly PA, Yang S, Connolly SJ: Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial. Lancet 2010; 376: 975-983.
49. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient isch-aemic attack. Lancet 2001; 358:1033-1041.
50. Chapma n N, Hu x ley R, Anderson C, Bou sser MG, Cha l mers J, Colma n S, Davis S, Donna n G, MacMahon S, Neal B, Warlow C, Woodward M: Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the Progress trial. Stroke 20 04; 35: 116-121. (Pubitemid 38057603)
51. Steiner T, Diringer M, Rosand J: Intracere-bra l hemorrhage associated with oral a ntico-agulant therapy: current practices and open questions. Stroke 2006; 37: 256-262. (Pubitemid 43732088)
52. Connolly SJ, Ezekowitz MD, Yusuf S, Eikel-boom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L: Da-bigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
53. The Executive Steering Committee on behalf of the Rocket AF Study Investigators: Rivar-oxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation: rationale and design of the Rocket AF study. Am Heart J 2010; 159:340-347 e341.
54. Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Com-merford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Mu-nawar M, O'Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S: Apixaban in patients with atrial fibrillation. N Engl J Med 2011; 364: 806-817.
55. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (Atria) study. JAMA 2001; 285: 2370-2375. (Pubitemid 32424106)
56. Stapf C: Endovascular management of un-ruptured intracranial aneurysms: the dawn of a multidisciplinary treatment paradigm. J Neurol Neurosurg Psychiatry 2006; 77:e1.
57. Stroke Unit Trialists' Collaboration: Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007; 4:CD000197.
58. Diringer MN, Edwards DF: Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001; 29:635-640. (Pubitemid 32225309)
59. Zahuranec DB, Morgenstern LB, Sanchez BN, Resnicow K, White DB, Hemphill JC 3rd: Do-not-resuscitate orders and predictive models after intracerebral hemorrhage. Neurolog y 2010; 75: 626-633.
60. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J: Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997; 28:1-5. (Pubitemid 27039454)
61. Mayer S, Brun N, Broderick J, Davis S, Di-ringer M, Skolnick B, Steiner T, for the FAST Trial Investigators: Efficacy and safety of re-combinant activated factor VII for acute in-tracerebral hemorrhage. N Engl J Med 2008; 358: 2127-2137. (Pubitemid 351679599)
62. Steiner T, Schneider D, Mayer S, Begtrup K, Broderick J, Diringer M, Skolnick B, Davis S: Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recom-binant activated factor VII. Neurosurgery 2006; 59: 767-774.
63. Gebel JM Jr, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, Spilker J, Tomsick TA, Duldner J, Broderick JP: Natural history of perihematomal edema in patients with hy-peracute spontaneous intracerebral hemorrhage. Stroke 2002; 33: 2631-2635. (Pubitemid 35266434)
64. Arima H, Wang JG, Huang Y, Heeley E, Sku-lina C, Parsons MW, Peng B, Li Q, Su S, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Morgenstern LB, Chalmers J, Anderson CS: Significance of perihematomal edema in acute intracerebral hemorrhage: the Interact trial. Neurology 2009; 73: 1963-1968.
65. Barras C, Christensen S, MacGregor L, Tress B, Collins M, Skolnick BE, Davis S, Brode-rick J, Diringer M, Steiner T, Davis S: Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke 2009; 40: 1325-1331.
66. Piriyawat P, Morgenstern LB, Yawn D, Hall CE, Grotta JC: Treatment of acute intracerebral hemorrhage with e-aminocaproic acid-a pilot study. Neurocrit Care 2004; 1:47-51.
67. Sorimachi T, Fujii Y, Morita K, Tanaka R: Predictors of hematoma enlargement in patients with intracerebral hemorrhage treated with rapid administration of antifibrinolytic agents and strict blood pressure control. J Neurosurg 2007; 106:250-254. (Pubitemid 46203151)
68. Mayer S, Brun N, Broderick J, Davis S, Diringer M, Skolnick B, Steiner T, for the Europe/Australasia Novo Seven ICH Trial Investigators: Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-785.
69. Al-Shahi Salman R: Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage. Cochrane Database Syst Rev 2009; 4:CD005951.
70. Lethagen S, Bjorlin G: Effect of tranexamic acid on platelet function in normal volunteers. Eur J Haematol 1991; 47:77-78.
71. Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Mar-rero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S, for CRASH-2 trial collaborators: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
72. Henry DA, Carless PA, Moxey AJ, O'Connell D, Stokes BJ, McClelland B, Laupacis A, Fergusson D: Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007; 4:CD001886.
73. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE: Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg 2002; 97: 771-778. (Pubitemid 35222396)
74. Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V, Grubb RL Jr, Diringer MN: Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) in-tracerebral hemorrhage. Neurology 2001; 57: 18-24. (Pubitemid 32634845)
75. Schellinger PD, Fiebach JB, Hoffmann K, Becker K, Orakcioglu B, Koll mar R, Juttler E, Schramm P, Schwab S, Sartor K, Hacke W: Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra? Stroke 2003; 34: 1674-1679. (Pubitemid 36842624)
76. Zazulia AR, Diringer MN, Videen TO, Adams RE, Yundt K, Aiyagari V, Grubb RL Jr, Powers WJ: Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001; 21: 804-810. (Pubitemid 32613534)
77. Anderson CS, Huang Y, Wang JG, Arima H, Nea l B, Peng B, Heeley E, Skulina C, Parsons MW, Kim JS, Tao QL, Li YC, Jiang JD, Tai LW, Zhang JL, Xu E, Cheng Y, Heritier S, Morgenstern LB, Chalmers J: Intensive blood pressure reduction in acute cerebral haemorrhage trial (Interact): a randomised pilot tria l. Lancet Neurol 2008; 7: 391-399.
78. Qureshi AI, ATACH investigators: Antihy-pertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010; 38:637-648.
79. Steiner T, Bösel J: Options to restrict hema-toma expansion after spontaneous intrace-rebral hemorrhage. Stroke 2010; 41:402-409.
80. Delcourt C, Huang Y, Wang J, Heeley E, Lindley R, Stapf C, Tzourio C, Arima H, Parsons M, Sun J, Neal B, Chalmers J, Anderson C: The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (Interact2). Int J Stroke 2010; 5: 110-116.
81. Sacco S, Marini C, Toni D, Olivieri L, Carolei A: Incidence and 10-year survival of intra-cerebral hemorrhage in a population-based registry. Stroke 2009; 40: 394-399.
82. Staykov D, Huttner HB, Struffert T, Ganslandt O, Doerfler A, Schwab S, Bar-dutzky J: Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 2009; 40:3275-3280.
83. Huttner HB, Nagel S, Tognoni E, Kohrmann M, Juttler E, Orakcioglu B, Schellinger PD, Schwab S, Bardutzky J: Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydro-cephalus. Stroke 2007; 38: 183-187. (Pubitemid 46035625)
84. Fernandes HM, Gregson B, Siddique S, Men-delow AD: Surgery in intracerebral hemorrhage: the uncertainty continues. Stroke 2000; 31:2511-2516.
85. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, Karimi A, Shaw MD, Barer DH: Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracere-bral haematomas in the international surgical trial in intracerebral haemorrhage (Stich): a randomised trial. Lancet 2005; 9457:387-397. (Pubitemid 40179225)
86. Prasad K, Mendelow AD, Gregson B: Surgery for primary supratentorial intracerebral haemorrhage. Cochrane Database Syst Rev 2008; 4:CD000200.
87. Qureshi AI, Mendelow AD, Hanley DF: In-tracerebral haemorrhage. Lancet 2009; 373: 1632-164 4.
88. Wang WZ, Jiang B, Liu HM, Li D, Lu CZ, Zhao YD, Sander JW: Minimally invasive craniopuncture therapy vs conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke 2009; 4: 11-16.
89. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC: Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 2001; 56: 1294-1299. (Pubitemid 32455286)
90. Naff NJ, Carhuapoma JR, Williams MA, Bhardwaj A, Ulatowski JA, Bederson J, Bullock R, Schmutzhard E, Pfausler B, Keyl PM, Tuhrim S, Hanley DF: Treatment of in-traventricular hemorrhage with urokinase: effects on 30-day survival. Stroke 2000; 31: 841-847. (Pubitemid 30198425)
91. Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzhard E: Intraventricular thrombol-ysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 2004; 54:577-583.
92. Stapf C, van der Worp HB, Steiner T, Rinkel GJE, Nedeltchev K, Mast H, Dichgans M, Codonnier C, Chamorro A, Arnold A, Al-Shahi M: Stroke research priorities for the next decade-a supplement statement on in-tracranial haemorrhage. Cerebrovasc Dis 2007; 23: 318-319. (Pubitemid 46425803)